Insmed

159.19
Open
161.51
Market Cap
35.01B+
High
164.53
Low
157.52
Close
162.43
Volume
1.81M+
P/E Ratio
-25.30
Div/Yield
0.00%

About Insmed

Insmed Incorporated是一家生物製藥公司,專注於研究和開發吸入療法,致力於幫助患者對抗那些危及生命的肺部疾病。公司主推出的產品ARIKACE以及阿米卡星脂質體吸入劑,這是一種有效的吸入抗生素療法,已證實在治療肺部重感染時能顯著提升療效、安全性及便利性。該公司成立於1999年11月29日,位於美國弗吉尼亞州的英聯邦,並在新澤西州的Bridgewater擁有辦公地址:700 US Highway 202/206。更多資訊請瀏覽公司網站:http://www.insmed.com。

如何購買 Insmed (INSM)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 INSM

購買 INSM

透過 RockFlow App 或網頁端搜尋 INSM,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.